Bristol-Myers Squibb
Bristol-Myers Squibb (BMS) is a pharmaceutical company that operates approximately 75 research and development, manufacturing and distributing facilities in 27 countries on 6 continents. Its mission is to extend and enhance human life by providing the highest quality pharmaceuticals and healthcare products. These include therapies for cardiovascular, metabolic, infectious diseases, neuro sciences, immunology, inflammation and oncology.
Bristol-Myers Squibb has been located in Ireland since 1964. The company has two technical operations based in Dublin. Swords Laboratories based in Swords, Co. Dublin has been manufacturing bulk pharmaceuticals for 40 years. Due to continuing company expansion and growth BMS Cruiserath, Mulhuddart, Dublin 15 is a new facility that was built to support production demands.
Financial Data
-
31st Dec 18 Source: Estimated
- €547.5 million turnover
- 650 employees
-
31st Dec 17 Source: Estimated
- €441.6 million turnover
- 550 employees
- 3 more years available »
Ranking
By Turnover
(€547.5 million)- 143rd in Top Companies
- 19th in Health
- 17th in Pharma
- 27th in Manufacturing
By Employees
(650)- 294th in Top Companies
- 44th in Health
- 26th in Pharma
- 43rd in Manufacturing
-
- 650
- €547.5 million
Employees
- Noel Heaney CEO/Managing Director
Latest News
- Jan 21 Northern Ireland drops campaign for lower corporation tax rate
- Jan 21 Avolon executives share €27m in pay as revenues soar
- Jan 21 European shares fall on China virus fears
- Jan 21 ‘Significant progress’ made by NI’s prosecution service into Project Eagle sale
- Jan 21 O’Flynn says subsidiary ‘mistakenly’ sought permission for student apartments in Birmingham